1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. NATCO PHARMA LTD.
Natco Pharma Ltd. NSE: NATCOPHARM | BSE: 524816
Mid-range Performer
In 2 Starfolio Baskets
Download real time
1000.80 47.70 (5.00%)
37.70% Gain from 52W Low
3.1M
NSE+BSE Volume

NSE 05 Mar, 2026 3:59 PM (IST)

Watchlist

Portfolio

Alert
Product Launch
Natco Pharma launches blood cancer drug in the US market, with US sales of $3.2 billion See details

Natco Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents